New combo therapy shows promise for aggressive lung cancer
Disease control
Ongoing
This study tested a new treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer that has spread. The treatment combines low-dose radiation, an immunotherapy drug (durvalumab), and standard chemotherapy. The goal was to see if this combination could…
Phase: PHASE2 • Sponsor: You Lu • Aim: Disease control
Last updated May 09, 2026 04:32 UTC